MedTrace Logo

Mivacurium 0.2 mg/kg in Young (18 - 40 Years) and Elderly (= 80 Years) Patients

NCT05558137 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2023-11-07

No results posted yet for this study

Summary

The aim of this study is to determine the onset time, duration of action and effect on intubation conditions of mivacurium 0.2 mg/kg in elderly patients with age ≥ 80 years and in young patients aged 18 - 40 years.

Conditions

  • Onset Time of Mivacurium, Duration of Action of Mivacurium

Interventions

DRUG

Mivacurium

0.2 mg/kg based on ideal body weight calculated as height (cm) minus 105 for women and height (cm) minus 100 for men or actual body weight, whichever is lower

Sponsors & Collaborators

  • Matias Vested

    lead OTHER

Principal Investigators

  • Matias Vested · Rigshospitalet University of Copenhagen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-30
Primary Completion
2023-05-22
Completion
2023-05-25
FDA Drug
Yes

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05558137 on ClinicalTrials.gov